Delivery Order SPE2DR25D3101-SPE2DR26F5M66
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $86,658.21 to AmerisourceBergen Drug Corp for the supply of Kerendia 10 mg tablets (90-count units) on November 7, 2025, with an ultimate completion date of November 10, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency awarded a delivery order valued at $17,656.81 to AmerisourceBergen Drug Corp for the supply of Kerendia 10 mg tablets (30-count units) under a firm fixed price contract. The award, issued on August 19, 2025, with an ultimate completion date of August 20, 2025, represents a non-competitive delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location. This...
- The Defense Logistics Agency awarded a $5,211.66 delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Kerendia 10 mg tablets (90-count). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 29, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child contract, this delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $9,571.07 to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Kerendia 10 mg tablets (30-count packaging). This is a firm fixed-price delivery order with an ultimate completion date of September 23, 2025, and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 16, 2025, for the supply of Kerendia 10 mg tablets (30-count) with a ceiling value of $1,270.12. This competitively awarded, firm fixed-price delivery order is scheduled for completion by June 17, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Kerendia 10 mg tablets (30-count packages) with a ceiling value of $1,529.00. This is a firm fixed-price delivery order with no set-aside designation, representing a competitive award under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026....
- The Defense Logistics Agency awarded a delivery order valued at $2,430.89 to AmerisourceBergen Drug Corp on October 23, 2025, for the supply of Kerendia 10 mg tablets (90-count). The contract, which is competitively awarded with no set-aside designation, carries a firm fixed price and is scheduled for completion by October 24, 2025. AmerisourceBergen Drug Corp will perform this work from its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the...
- The Defense Logistics Agency awarded a $1,014.95 delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Kerendia 10 mg tablets (30-count units). This is a firm fixed price, non-set-aside contract with a completion date of September 12, 2025, and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The place of performance is AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,430.52 for Kerendia 10 mg tablets (90-count packaging) on July 15, 2025, with an ultimate completion date of July 16, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $3,708.36 to AmerisourceBergen Drug Corp for Kerendia 10 mg tablets (30-count packages) on June 18, 2025, with completion targeted for June 20, 2025. This firm fixed price delivery order was competitively awarded without set-aside designation and is being fulfilled from the contractor's facility in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- SPE2DR25D3101Indefinite Delivery Contract
- SPE2DR25D3101-SPE2DR26F5M66Delivery Order
The Defense Logistics Agency awarded a $27,113.89 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 30-tablet bottles of Kerendia 10 mg tablets. This award, issued on November 14, 2025, with an ultimate completion date of November 17, 2025, represents a non-competitive, direct order against an existing contract vehicle. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement serving military and veteran healthcare systems. The delivery location is specified as Conshohocken, PA 19428. This delivery order is issued under AmerisourceBergen Drug Corp's prime Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. This comprehensive global pharmaceutical support contract enables the company to supply a vast range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including critical medications, vaccines, and medical supplies across multiple therapeutic domains. The delivery order for Kerendia—a medication used in the treatment of chronic kidney disease—exemplifies the company's role in fulfilling ongoing federal medical supply requirements for the Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $27.1k | 11/14/25 |